ÜNAL, G. Et Al. 2016. Famotidine Is it a potentia new candidate for thetreatment of schizophrenia by inhibiting GSK 3beta. 29th ECNP congress .

ÜNAL, G., Dokumacı, A. H., Hazar Yavuz, A. N., AYCAN, M. B., Şahin, C., Keleş, R., ... ARICIOĞLU, F.(2016). Famotidine Is it a potentia new candidate for thetreatment of schizophrenia by inhibiting GSK 3beta . 29th ECNP congress

ÜNAL, GÖKHAN Et Al. "Famotidine Is it a potentia new candidate for thetreatment of schizophrenia by inhibiting GSK 3beta," 29th ECNP congress, 2016

ÜNAL, GÖKHAN Et Al. "Famotidine Is it a potentia new candidate for thetreatment of schizophrenia by inhibiting GSK 3beta." 29th ECNP congress , 2016

ÜNAL, G. Et Al. (2016) . "Famotidine Is it a potentia new candidate for thetreatment of schizophrenia by inhibiting GSK 3beta." 29th ECNP congress .

@conferencepaper{conferencepaper, author={GÖKHAN ÜNAL Et Al. }, title={Famotidine Is it a potentia new candidate for thetreatment of schizophrenia by inhibiting GSK 3beta}, congress name={29th ECNP congress}, city={}, country={}, year={2016}}